ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 1 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $955,000 | +4.6% | 4,569,553 | +22.3% | 0.00% | – |
| Q2 2022 | $913,000 | -7.8% | 3,737,554 | +7.7% | 0.00% | – |
| Q1 2022 | $990,000 | -65.3% | 3,468,944 | -31.9% | 0.00% | – |
| Q4 2021 | $2,854,000 | -45.4% | 5,094,899 | -0.5% | 0.00% | – |
| Q3 2021 | $5,223,000 | -25.9% | 5,120,684 | +0.2% | 0.00% | – |
| Q2 2021 | $7,052,000 | -18.9% | 5,110,592 | -0.1% | 0.00% | – |
| Q1 2021 | $8,698,000 | +76.4% | 5,116,610 | +28.7% | 0.00% | – |
| Q4 2020 | $4,931,000 | -15.0% | 3,976,003 | -2.6% | 0.00% | – |
| Q3 2020 | $5,799,000 | +28.8% | 4,083,918 | +9.7% | 0.00% | – |
| Q2 2020 | $4,504,000 | +5.2% | 3,722,340 | +2.6% | 0.00% | – |
| Q1 2020 | $4,280,000 | -42.4% | 3,627,098 | +3.0% | 0.00% | – |
| Q4 2019 | $7,432,000 | -4.5% | 3,522,397 | -0.4% | 0.00% | – |
| Q3 2019 | $7,779,000 | -8.9% | 3,535,761 | +4.7% | 0.00% | – |
| Q2 2019 | $8,542,000 | -16.1% | 3,376,567 | +15.5% | 0.00% | – |
| Q1 2019 | $10,178,000 | +53.2% | 2,924,605 | +1.7% | 0.00% | – |
| Q4 2018 | $6,642,000 | -17.3% | 2,875,277 | +37.9% | 0.00% | – |
| Q3 2018 | $8,030,000 | +44.1% | 2,085,556 | +26.3% | 0.00% | – |
| Q2 2018 | $5,574,000 | +73.3% | 1,651,587 | +7.8% | 0.00% | – |
| Q1 2018 | $3,217,000 | +2.3% | 1,531,931 | -1.4% | 0.00% | – |
| Q4 2017 | $3,146,000 | -50.5% | 1,553,430 | +12.4% | 0.00% | – |
| Q3 2017 | $6,360,000 | +118.0% | 1,382,645 | +1.9% | 0.00% | – |
| Q2 2017 | $2,918,000 | -39.8% | 1,357,461 | -11.8% | 0.00% | – |
| Q1 2017 | $4,849,000 | +23.0% | 1,539,535 | +1.5% | 0.00% | – |
| Q4 2016 | $3,943,000 | -31.9% | 1,516,574 | +1.9% | 0.00% | – |
| Q3 2016 | $5,791,000 | +48.1% | 1,488,741 | +2.4% | 0.00% | – |
| Q2 2016 | $3,911,000 | +0.5% | 1,453,751 | +15.1% | 0.00% | – |
| Q1 2016 | $3,890,000 | -16.8% | 1,262,734 | +4.0% | 0.00% | – |
| Q4 2015 | $4,673,000 | -97.6% | 1,213,759 | -82.6% | 0.00% | -100.0% |
| Q3 2015 | $195,099,000 | +4175.7% | 6,961,838 | +546.9% | 0.01% | – |
| Q2 2015 | $4,563,000 | +7.8% | 1,076,226 | -1.8% | 0.00% | – |
| Q1 2015 | $4,231,000 | -35.4% | 1,095,839 | +12.6% | 0.00% | – |
| Q4 2014 | $6,550,000 | +39.7% | 973,367 | +14.0% | 0.00% | – |
| Q3 2014 | $4,687,000 | -43.5% | 853,624 | +5.4% | 0.00% | -100.0% |
| Q2 2014 | $8,299,000 | -11.7% | 809,648 | +3.5% | 0.00% | 0.0% |
| Q1 2014 | $9,399,000 | +26.5% | 782,566 | +19.1% | 0.00% | 0.0% |
| Q4 2013 | $7,429,000 | +13.2% | 656,867 | +7.8% | 0.00% | 0.0% |
| Q3 2013 | $6,560,000 | +38.3% | 609,100 | +19.0% | 0.00% | – |
| Q2 2013 | $4,745,000 | – | 511,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |